AAD  Vol.7 No.4 , December 2018
Longitudinal Follow-Up of a Population with MCI: Predictive Value of the MIS Test with Delayed Recall for Progression to Dementia
Background: Early detection of dementia is currently of great interest and of crucial importance for the implementation of preventive measures and treatment of the disease. Impairment in verbal episodic memory, and in particular in a delayed recall phase, is considered one of the early markers of progression from mild cognitive impairment (MCI) to dementia. Therefore, having cognitive screening instruments with predictive value for progression is of utmost importance. Objective: The purpose of this work is to show the predictive value, sensitivity and specificity of the Memory Impairment Screen with delayed recall (MIS-DR) to predict conversion to dementia in patients with MCI. Methods: In retrospective study 502 patients over 60 years old, evaluated in the Older Adult Functional Evaluation Unit of our hospital for cognitive complaint, were diagnosed with MCI. They were followed up to assess conversion to dementia. Results: During follow up, 144 participants developed dementia (28.6%, 95% CI 24.76 - 32.85) and the average time of progression to dementia were 23 months (SD 13.2). The cut-off point was established below 6 for MIS-DR and it showed a sensitivity of 76% (95% CI 68.77 - 77.84) and a specificity of 56% (95% CI 50.44 - 61.58), with a positive predictive value of 41% (95% CI 34.78 - 47.6) and a negative predictive value of 85% (95% CI 80.53 - 91.11) for predicting progression to dementia. Of those patients who obtained a MIS-DR score below 6, 41% developed dementia, in contrast to 14.53% of those with a score above or equal to 6, OR 4.09 (95% CI 2.64 - 6.34), p < 0.00001. There were no significant differences in terms of gender, education level or vascular risk factors among patients who converted and those who did not convert to dementia. Conclusion: We believe that MIS-DR is a useful and valid test to detect episodic memory impairment and to identify patients at risk of progression to dementia.
Cite this paper: Edith, L. , Marina, C. , Luis, C. , Bruno, B. and Marcelo, S. (2018) Longitudinal Follow-Up of a Population with MCI: Predictive Value of the MIS Test with Delayed Recall for Progression to Dementia. Advances in Alzheimer's Disease, 7, 183-196. doi: 10.4236/aad.2018.74012.

[1]   Vellas, B., Aisen, P.S., Sampaio, C., Carrillo, M., Scheltens, P., Scherrer, B., et al. (2011) Prevention Trials in Alzheimer’s Disease: An EU-US Task Force Report. Progress in Neurobiology, 95, 594-600.

[2]   Villemagne, V.L., Burnham, S., Bourgeat, P., Brown, B., Ellis, K.A., Salvado, O., et al. (2013) Amyloid β Deposition, Neurodegeneration, and Cognitive Decline in Sporadic Alzheimer’s Disease: A Prospective Cohort Study. The Lancet Neurology, 12, 357-367.

[3]   Sperling, R.A., Aisen, P.S., Beckett, L.A., Bennett, D.A., Craft, S., Fagan, A.M., et al. (2011) Toward Defining the Preclinical Stages of Alzheimer’s Disease: Recom-Mendations from the National Institute on Aging-Alzheimer’s Association Workgroups on Diagnostic Guidelines for Alzheimer’s Disease. Alzheimer’s & Dementia, 7, 280-292.

[4]   Albert, M.S., DeKosky, S.T., Dickson, D., Dubois, B., Feldman, H.H., Fox, N.C., et al. (2011) The Diagnosis of Mild Cognitive Impairment Due to Alzheimer’s Disease: Recommendations from the National Institute on Aging-Alzheimer’s Association Workgroups on Diagnostic Guidelines for Alzheimer’s Disease. Alzheimer’s & Dementia, 7, 270-279.

[5]   Petersen, R.C., Stevens, J.C., Ganguli, M., Tangalos, E.G., Cummings, J.L. and DeKosky, S.T. (2001) Practice Parameter: Early Detection of Dementia: Mild Cognitive Impairment (an Evidence-Based Review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology, 56, 1133-1142.

[6]   Farias, S.T., Mungas, D., Reed, B.R., Harvey, D. and DeCarli, C. (2009) Progression of Mild Cognitive Impairment to Dementia in Clinicvs Community-Based Cohorts. Archives of Neurology, 66, 1151-1157.

[7]   Mitchell, A.J. and Shiri-Feshki, M. (2009) Rate of Progression of Mild Cognitive Im-Pairment to Dementia—Meta-Analysis of 41 Robust Inception Cohort Studies. Acta Psychiatrica Scandinavica, 119, 252-265.

[8]   Mitchell, A.J., Beaumont, H., Ferguson, D., Yadegarfar, M. and Stubbs, B. (2014) Risk of Dementia and Mild Cognitive Impairment in Older People with Subjective Memory Complaints: Meta-Analysis. Acta Psychiatrica Scandinavica, 130, 439-451.

[9]   Tabert, M.H., Manly, J.J., Liu, X., Pelton, G.H., Rosenblum, S., Jacobs, M., et al. (2006) Neuropsychological Prediction of Conversion to Alzheimer Disease in Patients With Mild Cognitive Impairment. Archives of General Psychiatry, 63, 916-924.

[10]   Bruscoli, M. and Lovestone, S. (2004) Is MCI Really Just Early Dementia? A Systematic Review of Conversion Studies. International Psychogeriatrics, 16,129-140.

[11]   Hayden, K.M., Kuchibhatla, M., Romero, H.R., Plassman, B.L., Burke, J.R., Browndyke, J.N., et al. (2014) Pre-Clinical Cognitive Phenotypes for Alzheimer Disease: A Latent Profile Approach. The American Journal of Geriatric Psychiatry, 22, 1364-1374.

[12]   Cerami, C., Dubois, B., Boccardi, M., Monsch, A.U., Demonet, J.F., Cappa, S.F., et al. (2017) Clinical Validity of Delayed Recall Tests as a Gateway Biomarker for Alzheimer’s Disease in the Context of a Structured 5-Phase Development Framework. Neurobiology of Aging, 52, 153-166.

[13]   Dubois, B., Feldman, H.H., Jacova, C., Cummings, J.L., Dekosky, S.T., Barberger-Gateau, P., et al. (2010) Revising the Definition of Alzheimer’s Disease: A New Lexicon. The Lancet Neurology, 9, 1118-1127.

[14]   Dubois, B., Feldman, H.H., Jacova, C., Hampel, H., Molinuevo, J.L., Blennow, K., et al. (2014) Advancing Research Diagnostic Criteria for Alzheimer’s Disease: The IWG-2 Criteria. The Lancet Neurology, 13, 614-629.

[15]   Dubois, B., Feldman, H.H., Jacova, C., Dekosky, S.T., Barberger-Gateau, P., Cummings, J., et al. (2007) Research Criteria for the Diagnosis of Alzheimer’s Disease: Revising the NINCDS-ADRDA Criteria. The Lancet Neurology, 6, 734-746.

[16]   Takayama, Y. (2010) A Delayed Recall Battery as a Sensitive Screening for Mild Cognitive Impairment: Follow-Up Study of Memory Clinic Patients after 10 Years. Journal of Medical and Dental Sciences, 57, 177-184.

[17]   Gauthier, S., Dubois, B., Feldman, H. and Scheltens, P. (2008) Revised Research Diagnostic Criteria for Alzheimer’s Disease. The Lancet Neurology, 7, 668-670.

[18]   Fleisher, A.S., Sun, S., Taylor, C., Ward, C.P., Gamst, A.C., Petersen, R.C., et al. (2008) Volumetric MRI vs. Clinical Predictors of Alzheimer Disease in Mild Cognitive Impairment. Neurology, 70, 191-199.

[19]   Pozueta, A., Rodríguez-Rodríguez, E., Vazquez-Higuera, J.L., Mateo, I., Sánchez-Juan, P., González-Perez, S., et al. (2011) Detection of Early Alzheimer’s Disease in MCI Patients by the Combination of MMSE and an Episodic Memory Test. BMC Neurology, 11, 78.

[20]   Prins, N.D., van der Flier, W.M., Brashear, H.R., Knol, D.L., van de Pol, L.A., Barkhof, F., et al. (2013) Predictors of Progression from Mild Cognitive Impairment to Dementia in the Placebo-Arm of a Clinical Trial Population. Journal of Alzheimer’s Disease, 36, 79-85.

[21]   Espinosa, A., Alegret, M., Valero, S., Vinyes-Junqué, G., Hernández, I., Mauleón, A., et al. (2013) A Longitudinal Follow-Up of 550 Mild Cognitive Impairment Patients: Evidence for Large Conversion to Dementia Rates and Detection of Major Risk Factors Involved. Journal of Alzheimer’s Disease, 34, 769-780.

[22]   Gainotti, G., Quaranta, D., Vita, M.G. and Marra, C. (2014) Neuropsychological Predictors of Conversion from Mild Cognitive Impairment to Alzheimer’s Disease. Journal of Alzheimer’s Disease, 38, 481-495.

[23]   Cloutier, S., Chertkow, H., Kergoat, M.-J., Gauthier, S. and Belleville, S. (2015) Patterns of Cognitive Decline Prior to Dementia in Persons with Mild Cognitive Impairment. Journal of Alzheimer’s Disease, 47, 901-913.

[24]   Weissberger, G.H., Strong, J.V., Stefanidis, K.B., Summers, M.J., Bondi, M.W. and Stricker, N.H. (2017) Diagnostic Accuracy of Memory Measures in Alzheimer’s Dementia and Mild Cognitive Impairment: A Systematic Review and Meta-Analysis. Neuropsychology Review, 27, 354-388.

[25]   Li, J.-Q., Tan, L., Wang, H.-F., Tan, M.-S., Tan, L., Xu, W., et al. (2016) Risk Factors for Predicting Progression from Mild Cognitive Impairment to Alzheimer’s Disease: A Systematic Review and Meta-Analysis of Cohort Studies. Journal of Neurology, Neurosurgery, and Psychiatry, 87, 476-484.

[26]   Edith, L., Sofía, T., Daniel, S., Marcelo, S. and Alejandro, R. (2015) Spanish Version of Test MIS (*) with Delayed Memory Recall Normative Values and Results in a Population with Mild Cognitive Impairment. Advances in Alzheimer’s Disease, 4, 45-61.

[27]   Buschke, H., Kuslansky, G., Katz, M., Stewart, W.F., Sliwinski, M.J., Eckholdt, H.M., et al. (1999) Screening for Dementia with the Memory Impairment Screen. Neurology, 52, 231-238.

[28]   Katz, S. (1963) Studies of Illness in the Aged. Journal of the American Medical Association, 185, 914-919.

[29]   Lawton, M.P. and Brody, E.M. (1969) Assessment of Older People: Self-Maintaining and Instrumental Activities of Daily Living. Gerontologist, 9, 179-186.

[30]   Brink, T.L. (1986) Clinical Gerontology: A Guide to Assessment and Intervention. Psychology Press.

[31]   Hughes, C.P., Berg, L., Danziger, W.L., Coben, L.A. and Martin, R.L. (1982) A New Clinical Scale for the Staging of Dementia. The British Journal of Psychiatry, 140, 566-572.

[32]   Folstein, M.F., Folstein, S.E. and McHugh, P.R. (1975) Mini-Mental State. A Practical Method for Grading the Cognitive State of Patients for the Clinician. Journal of Psychiatric Research, 12, 189-198.

[33]   Eshkoor, S.A., Hamid, T.A., Mun, C.Y. and Ng, C.K. (2015) Mild Cognitive Impairment and Its Management in Older People. Clinical Interventions in Aging, 10, 687-693.

[34]   Langa, K.M. and Levine, D.A. (2014) The Diagnosis and Management of Mild Cognitive Impairment: A Clinical Review. JAMA, 312, 2551-2561.

[35]   Marra, C., Ferraccioli, M., Vita, M.G., Quaranta, D. and Gainotti, G. (2011) Patterns of Cognitive Decline and Rates of Conversion to Dementia in Patients with Degenerative and Vascular Forms of MCI. Current Alzheimer Research, 8, 24-31.

[36]   Perri, R., Serra, L., Carlesimo, G.A. and Caltagirone, C. (2007) Early Diagnosis Group of the Italian Interdisciplinary Network on Alzheimer’s Disease. Amnestic Mild Cognitive Impairment: Difference of Memory Profile in Subjects Who Converted or Did Not Convert to Alzheimer’s Disease. Neuropsychology, 21, 549-558.

[37]   Sano, M., Raman, R., Emond, J., Thomas, R.G., Petersen, R., Schneider, L.S., et al. (2011) Adding Delayed Recall to the Alzheimer Disease Assessment Scale Is Useful in Studies of Mild Cognitive Impairment But Not Alzheimer Disease. Alzheimer Disease & Associated Disorders, 25, 122-127.

[38]   Eldholm, R.S., Persson, K., Barca, M.L., Knapskog, A.-B., Cavallin, L., Engedal, K., et al. (2018) Association between Vascular Comorbidity and Progression of Alzheimer’s Disease: A Two-Year Observational Study in Norwegian Memory Clinics. BMC Geriatrics, 18, 120.